Atena Mansouri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Atena Mansouri has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Amirhossein Sahebkar
Mashhad University of Medical Sciences
2 shared publications Jamshid Mehrzad
Department of Biochemistry, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran; Advanced Research Center for Chemistry, Biochemistry and Nanomaterial, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran
2 shared publicationsMasood Homayouni
Department of Biology, Mashhad branch, Islamic Azad university, Mashhad, Iran
2 shared publications- Mehran Gholamin
Department of Laboratory Sciences, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran
2 shared publications - Mohammad Ramezani
Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
2 shared publications Ramin Vosooghi
Department of Biochemistry, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran
2 shared publications
Latest Publications
- Open Access
- 28 July 2025
- Vol. 14  (4) , 1072-1083
Achillea biebersteinii-Mediated Gold Nanoparticles on Oocyte Gene Expression and Follicular Development in Mice
This study investigated the effects of chemically synthesized gold nanoparticles (GNPs) and green gold nanoparticles (gGNPs) derived from Achillea biebersteinii extract on antrum diameter and the expression of genes associated with follicular development in NMRI mice. Female mice were treated with GNPs and gGNPs at concentrations of 10, 50, and 100 µg/mL. Antrum diameter in ovarian follicles was measured using ImageJ software. Gene expression levels of BMP-15, GDF-9, SOD, and GPx were quantified via real-time PCR.Treatment with gGNPs at 100 µg/mL significantly increased the antrum diameter of secondary follicles compared to GNPs (p ⤠0.05), while no significant changes were observed in grafted follicles. A dose-dependent upregulation of BMP-15, GDF-9, GPx, and SOD was observed in both GNP and gGNP groups, with gGNPs eliciting stronger effects across all genes (p ⤠0.05). The findings suggest that A. biebersteinii-mediated green synthesis enhances the biological activity of GNPs, particularly in promoting follicular development and antioxidant gene expression. Although mechanistic pathways were not explored in this study, future research should address these gaps and evaluate long-term safety and therapeutic potential.
- 28 July 2025
- Vol. 14  (4) , 1072-1083
Open AccessAchillea biebersteinii-Mediated Gold Nanoparticles on Oocyte Gene Expression and Follicular Development in Mice
This study investigated the effects of chemically synthesized gold nanoparticles (GNPs) and green gold nanoparticles (gGNPs) derived from Achillea biebersteinii extract on antrum diameter and the expression of genes associated with follicular development in NMRI mice. Female mice were treated with GNPs and gGNPs at concentrations of 10, 50, and 100 µg/mL. Antrum diameter in ovarian follicles was measured using ImageJ software. Gene expression levels of BMP-15, GDF-9, SOD, and GPx were quantified via real-time PCR.Treatment with gGNPs at 100 µg/mL significantly increased the antrum diameter of secondary follicles compared to GNPs (p ⤠0.05), while no significant changes were observed in grafted follicles. A dose-dependent upregulation of BMP-15, GDF-9, GPx, and SOD was observed in both GNP and gGNP groups, with gGNPs eliciting stronger effects across all genes (p ⤠0.05). The findings suggest that A. biebersteinii-mediated green synthesis enhances the biological activity of GNPs, particularly in promoting follicular development and antioxidant gene expression. Although mechanistic pathways were not explored in this study, future research should address these gaps and evaluate long-term safety and therapeutic potential.
- Open Access
- 1 January 2025
- Published by Wiley in Dermatology Research and Practice
- Vol. 2025  (1) , 9764336
Thymoquinone Inhibits Proliferation and Induces Apoptosis in Immortalized Keratinocytes via Upregulation of p53 Expression
Introduction: Psoriasis, as a common inflammatory skin disease, is characterized by hyperproliferation of epidermal keratinocytes and induction of an inflammatory response. Apoptosis induction and prevention of the proliferation of keratinocytes can help to treat and manage this disease. Thymoquinone (TQ), a bioactive compound with antioxidant and antiâinflammatory properties, has also been reported as a natural antitumor agent. This study aimed to evaluate the effects of TQ on proliferation and apoptosis in human keratinocyte cells (HaCaT). Methods: HaCaT cells were treated with increasing concentrations of TQ (1, 2, 4, 6, 8, 16, 32, and 64 Îĵg/mL), and cell viability was assessed using the MTT assay. Apoptosis was analyzed via flow cytometry using Annexin VâFITC/PI staining. Expression levels of p53, Bax, and BCLâxl genes were measured by realâtime PCR. Results: TQ significantly reduced cell viability in a doseâdependent manner, with an IC50 of 11.64 Îĵg/mL after 72 h. Flow cytometry revealed a marked increase in early apoptotic cells following treatment with 8 Îĵg/mL TQ (41.00% Âħ 5.04%) compared to control (17.8% Âħ 2.26%, P ⤠0.001). Gene expression analysis showed significant upregulation of p53, while Bax and BCLâxl levels showed no significant changes. Conclusion: TQ induces apoptosis in human HaCaT cells primarily through p53âdependent pathways, suggesting its potential as a therapeutic agent for skinârelated disorders .
- 1 January 2025
- Published by Wiley in Dermatology Research and Practice
- Vol. 2025  (1) , 9764336
Open AccessThymoquinone Inhibits Proliferation and Induces Apoptosis in Immortalized Keratinocytes via Upregulation of p53 Expression
Introduction: Psoriasis, as a common inflammatory skin disease, is characterized by hyperproliferation of epidermal keratinocytes and induction of an inflammatory response. Apoptosis induction and prevention of the proliferation of keratinocytes can help to treat and manage this disease. Thymoquinone (TQ), a bioactive compound with antioxidant and antiâinflammatory properties, has also been reported as a natural antitumor agent. This study aimed to evaluate the effects of TQ on proliferation and apoptosis in human keratinocyte cells (HaCaT). Methods: HaCaT cells were treated with increasing concentrations of TQ (1, 2, 4, 6, 8, 16, 32, and 64 Îĵg/mL), and cell viability was assessed using the MTT assay. Apoptosis was analyzed via flow cytometry using Annexin VâFITC/PI staining. Expression levels of p53, Bax, and BCLâxl genes were measured by realâtime PCR. Results: TQ significantly reduced cell viability in a doseâdependent manner, with an IC50 of 11.64 Îĵg/mL after 72 h. Flow cytometry revealed a marked increase in early apoptotic cells following treatment with 8 Îĵg/mL TQ (41.00% Âħ 5.04%) compared to control (17.8% Âħ 2.26%, P ⤠0.001). Gene expression analysis showed significant upregulation of p53, while Bax and BCLâxl levels showed no significant changes. Conclusion: TQ induces apoptosis in human HaCaT cells primarily through p53âdependent pathways, suggesting its potential as a therapeutic agent for skinârelated disorders .
- 20 December 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317  (1) , 1-16
Topical formulation of Boswellia nano emulsion in psoriasis mouse model
Organ-specific autoimmune inflammatory skin disease is called psoriasis. Pharmacological study indicates that Boswellia serrata (BS) gum resin is an active herbal element that has a significant role in the management of inflammatory diseases. Because BAs are steroidal (lipophilic), their systemic bioavailability is restricted. Thermodynamically stable, transparent, optically isotropic, and oil-surfactant mixes with a small droplet size and excellent solubility capacity for lipophilic drugs are known as nano emulsions.In the present study, will test the production of Boswellia nano emulsion gel (BNG) on cells and then on mice skin. Male Balb/c mice were given topical application of imiquimod (IMQ) to the right ear pinna surface for 10 days in order to induce dermatitis similar to psoriasis. On the tenth day of the study, each ear was examined for inflammation. Proliferation and fibrosis are examined histopathologically (using Massonâs trichrome and H&E staining) Gene expression analysis of IL-17, IL-23, and TNF-Îħ was conducted using real-time PCR. The results confirmed that the IMQ-induced psoriasis lasted for five days. However, in contrast to the control group, BNG significantly reduced body weight as well as the thickness, length, psoriatic itch, and skin inflammation The results showed a significant increase in the expression levels of all three genes in the negative control group and decrease in treat and positive control. All things considered, topical BNG significantly reduced both the macroscopic and microscopic features of psoriasis. To translate the benefits to clinics, more clinical research is necessary. However, further clinical investigations are required to translate the effects to clinics.
- 20 December 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317  (1) , 1-16
Topical formulation of Boswellia nano emulsion in psoriasis mouse model
Organ-specific autoimmune inflammatory skin disease is called psoriasis. Pharmacological study indicates that Boswellia serrata (BS) gum resin is an active herbal element that has a significant role in the management of inflammatory diseases. Because BAs are steroidal (lipophilic), their systemic bioavailability is restricted. Thermodynamically stable, transparent, optically isotropic, and oil-surfactant mixes with a small droplet size and excellent solubility capacity for lipophilic drugs are known as nano emulsions.In the present study, will test the production of Boswellia nano emulsion gel (BNG) on cells and then on mice skin. Male Balb/c mice were given topical application of imiquimod (IMQ) to the right ear pinna surface for 10 days in order to induce dermatitis similar to psoriasis. On the tenth day of the study, each ear was examined for inflammation. Proliferation and fibrosis are examined histopathologically (using Massonâs trichrome and H&E staining) Gene expression analysis of IL-17, IL-23, and TNF-Îħ was conducted using real-time PCR. The results confirmed that the IMQ-induced psoriasis lasted for five days. However, in contrast to the control group, BNG significantly reduced body weight as well as the thickness, length, psoriatic itch, and skin inflammation The results showed a significant increase in the expression levels of all three genes in the negative control group and decrease in treat and positive control. All things considered, topical BNG significantly reduced both the macroscopic and microscopic features of psoriasis. To translate the benefits to clinics, more clinical research is necessary. However, further clinical investigations are required to translate the effects to clinics.
- 29 July 2023
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
The effect of trehalose administration on the serum expression levels of microRNAs associated with lipid metabolism and autophagy process in patients with myocardial infarction - the post-hoc analysis of the TREAT-IR trial.
Introduction: This study aimed to evaluate the TRE-induced changes in the serum expression levels of miRNAs associated with lipids metabolism and autophagy process in MI patients to assess the potential protective effects of TRE in these patients.Material and methods: This post hoc investigation was performed on serum samples obtained from a pilot randomized, double blind, placebo-controlled clinical trial that recruited 14 men (aged 18-80) who had MI and systemic inflammation. The patients were randomized in a 2:1 ratio to either TRE (15 g/week, intravenous (IV) ad-ministration) (N=10) or placebo groups (equal volume of saline 0.9 %) (N=4) for a period of 12 weeks. To measure the relative serum expression levels of miRNA-155, miRNA-221, and miRNA-33, the SYBR Green qPCR method was used.Results: miRNA-155 showed significantly higher serum expression levels in the TRE group (2.772Âħ0.73; P=0.009) when compared to the placebo group. Also, significant reductions in miRNA-155 (0.171Âħ0.03; P=0.016), miRNA-221 (0.116Âħ0.07; P=0.013), and miRNA-33a (0.076Âħ0.07; P=0.025) were observed in the placebo group at the end of the study. Nevertheless, the reduction (normalized to the baseline) of the serum expres-sion levels of miRNA-221 (FC:0.87Âħ0.20 vs FC:0.18Âħ0.08; P=0.009) and miRNA-33a (FC:0.73Âħ0.22 vs FC:0.13Âħ0.08; P=0.025) were significantly less in TRE group than in the placebo group.Conclusions: IV TRE administration did not reduce the expression of miRNA-221 and miRNA33a as much as placebo. Keeping a steady state of the serum expression levels of these miRNAs associated with lipoproteins metabolism and autophagy in the TRE group might have protective effects in patients with MI.
- 29 July 2023
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
The effect of trehalose administration on the serum expression levels of microRNAs associated with lipid metabolism and autophagy process in patients with myocardial infarction - the post-hoc analysis of the TREAT-IR trial.
Introduction: This study aimed to evaluate the TRE-induced changes in the serum expression levels of miRNAs associated with lipids metabolism and autophagy process in MI patients to assess the potential protective effects of TRE in these patients.Material and methods: This post hoc investigation was performed on serum samples obtained from a pilot randomized, double blind, placebo-controlled clinical trial that recruited 14 men (aged 18-80) who had MI and systemic inflammation. The patients were randomized in a 2:1 ratio to either TRE (15 g/week, intravenous (IV) ad-ministration) (N=10) or placebo groups (equal volume of saline 0.9 %) (N=4) for a period of 12 weeks. To measure the relative serum expression levels of miRNA-155, miRNA-221, and miRNA-33, the SYBR Green qPCR method was used.Results: miRNA-155 showed significantly higher serum expression levels in the TRE group (2.772Âħ0.73; P=0.009) when compared to the placebo group. Also, significant reductions in miRNA-155 (0.171Âħ0.03; P=0.016), miRNA-221 (0.116Âħ0.07; P=0.013), and miRNA-33a (0.076Âħ0.07; P=0.025) were observed in the placebo group at the end of the study. Nevertheless, the reduction (normalized to the baseline) of the serum expres-sion levels of miRNA-221 (FC:0.87Âħ0.20 vs FC:0.18Âħ0.08; P=0.009) and miRNA-33a (FC:0.73Âħ0.22 vs FC:0.13Âħ0.08; P=0.025) were significantly less in TRE group than in the placebo group.Conclusions: IV TRE administration did not reduce the expression of miRNA-221 and miRNA33a as much as placebo. Keeping a steady state of the serum expression levels of these miRNAs associated with lipoproteins metabolism and autophagy in the TRE group might have protective effects in patients with MI.
- Open Access
- 20 July 2023
- Published by Springer Nature in Research Square
Investigating the effect of hesperitine on estrogen receptor expression, phosphorylation and activity in MCF-7 cells
Background The most typical malignancy among women worldwide is breast cancer. Estrogen receptor play a vital role in this cancer. One of the most known mechanisms that affect the activity of this receptor is its phosphorylation by protein kinase pathways. Studies have shown that hesperetin has an effect on intracellular kinase pathways. Purpose The aim of this study was to investigate the effect of hesperetin on the level of expression, phosphorylation and activity of estrogen receptor . Study design and methods: MCF-7 cells were cultured in RPMI 1640 phenol red free medium containing charcoal stripped FBS and treated with hesperetin. MTT method was used to evaluate cell survival. The level of ERÎħ protein and its phosphorylated form (Ser118) was determined by western blot technique. Luciferase reporter vector was used to evaluate ERE activity. Results The results of this study indicated that hesperetin reduced the survival of MCF-7 cells in a dose dependent manner. The level of expression and phosphorylation (Ser118) of estrogen receptor indicated a significant increase and decrease in the groups treated with hesperetin, respectively. Hesperetin increased the activity of the estrogen receptor in the nonexistence of E2, while in the existence of E2 it caused a significant decrease in receptor activity. Conclusion Based on the results of this study, it can be concluded that hesperetin has a significant effect on estrogen receptor expression, phosphorylation and activity probably through protein kinase pathways.
- 20 July 2023
- Published by Springer Nature in Research Square
Open AccessInvestigating the effect of hesperitine on estrogen receptor expression, phosphorylation and activity in MCF-7 cells
Background The most typical malignancy among women worldwide is breast cancer. Estrogen receptor play a vital role in this cancer. One of the most known mechanisms that affect the activity of this receptor is its phosphorylation by protein kinase pathways. Studies have shown that hesperetin has an effect on intracellular kinase pathways. Purpose The aim of this study was to investigate the effect of hesperetin on the level of expression, phosphorylation and activity of estrogen receptor . Study design and methods: MCF-7 cells were cultured in RPMI 1640 phenol red free medium containing charcoal stripped FBS and treated with hesperetin. MTT method was used to evaluate cell survival. The level of ERÎħ protein and its phosphorylated form (Ser118) was determined by western blot technique. Luciferase reporter vector was used to evaluate ERE activity. Results The results of this study indicated that hesperetin reduced the survival of MCF-7 cells in a dose dependent manner. The level of expression and phosphorylation (Ser118) of estrogen receptor indicated a significant increase and decrease in the groups treated with hesperetin, respectively. Hesperetin increased the activity of the estrogen receptor in the nonexistence of E2, while in the existence of E2 it caused a significant decrease in receptor activity. Conclusion Based on the results of this study, it can be concluded that hesperetin has a significant effect on estrogen receptor expression, phosphorylation and activity probably through protein kinase pathways.
- Open Access
- 29 June 2023
- Published by Springer Nature in Research Square
A study conducted in breast cancer cells found that (valproic acid) inhibits CIP2A/C-MYC/PI3K/Akt/mTOR signaling molecules and PD-L1
Background Resistant cells are a critical problem that reduce treatment efficacy of breast cancer. Nowadays, CIP2A and PD-L1 are considered as theraputical challenges in breast cancer, because of responsible for drug resistance and immune evasion respectively. Hence, identifying agents to suppress these factors is great of interest. Specifically, epigenetic drugs can be an effective approach to alter the behavior of genes. Objective The objective of this study is to evaluate the drug effects and molecular mechanisms of valproic acid (VPA) as a HDAC inhibitor, particularly its effect on CIP2A and PD-L1 in breast cancer MCF-7 cell line. Materials and Methods In this study, MCF-7 cells were treated with various concentration of VPA for 24 h, 48 h, and 72 h. The rate of cell viability was measured by MTT assay. Finally, gene expressions of CIP2A, c-MYC, PI3K, Akt, mTOR and PD-L1 were analyzed by real time PCR and ÎCT method. Result VPA showed a growth inhibitory effect in MCF-7 cell line. This effect is achieved by decreasing the expression levels of CIP2A oncogene and its downstream signaling molecules i.e. c-MYC, PI3K, Akt and mTOR. In addition to being a CIP2A targeting agent, VPA also inhibits PD-L1 in MCF-7 cell line. Conclusions Our findings suggest that VPA can be a novel approach to combat with challenges caused by CIP2A and PD-L1, thereby alone or in combination with existing therapies could be promising strategy to get more efficiencies in treatments for breast cancer patients.
- 29 June 2023
- Published by Springer Nature in Research Square
Open AccessA study conducted in breast cancer cells found that (valproic acid) inhibits CIP2A/C-MYC/PI3K/Akt/mTOR signaling molecules and PD-L1
Background Resistant cells are a critical problem that reduce treatment efficacy of breast cancer. Nowadays, CIP2A and PD-L1 are considered as theraputical challenges in breast cancer, because of responsible for drug resistance and immune evasion respectively. Hence, identifying agents to suppress these factors is great of interest. Specifically, epigenetic drugs can be an effective approach to alter the behavior of genes. Objective The objective of this study is to evaluate the drug effects and molecular mechanisms of valproic acid (VPA) as a HDAC inhibitor, particularly its effect on CIP2A and PD-L1 in breast cancer MCF-7 cell line. Materials and Methods In this study, MCF-7 cells were treated with various concentration of VPA for 24 h, 48 h, and 72 h. The rate of cell viability was measured by MTT assay. Finally, gene expressions of CIP2A, c-MYC, PI3K, Akt, mTOR and PD-L1 were analyzed by real time PCR and ÎCT method. Result VPA showed a growth inhibitory effect in MCF-7 cell line. This effect is achieved by decreasing the expression levels of CIP2A oncogene and its downstream signaling molecules i.e. c-MYC, PI3K, Akt and mTOR. In addition to being a CIP2A targeting agent, VPA also inhibits PD-L1 in MCF-7 cell line. Conclusions Our findings suggest that VPA can be a novel approach to combat with challenges caused by CIP2A and PD-L1, thereby alone or in combination with existing therapies could be promising strategy to get more efficiencies in treatments for breast cancer patients.
- 27 January 2023
- Published by Elsevier
- p. 219-235
Aptamer-functionalized PLGA nanoparticles for targeted cancer therapy
- 27 January 2023
- Published by Elsevier
- p. 219-235
Aptamer-functionalized PLGA nanoparticles for targeted cancer therapy
- 29 September 2022
- Published by Springer Nature in Medical Oncology
- Vol. 39  (12) , 1-9
Establishment and characterization of chemotherapy-enriched sphere-forming cells with stemness phenotypes as a new cell line (BAG50) of gastric carcinoma
Gastric cancer is a malignancy with a high mortality rate worldwide. Cancer stem cells (CSCs) are a small subpopulation of tumor cells that possess the tumor-initiating ability, self-renewal capacity, and high resistance to conventional therapies. Due to the diversity and complexity of human tumors, new cell lines are urgently needed to supply clinically and physiologically relevant cancer models. Here, we report establishing a novel cell line (BAG50) with stemness properties. Chemotherapy-enriched sphere-forming cells with CSC properties isolated from a patient with GC were cultured in a serum-containing medium and passaged for up to 51 passages. The colony-forming ability and tumor-forming capacity of BAG50 cells were evaluated in vitro and in vivo. mRNA upregulation of stemness-related transcriptional factors using real-time PCR as well as expression of CSC markers using flow cytometry was investigated. Finally, STR profiling and chromosome studies were performed. BAG50 cells formed floating spheroid colonies in a serum-free medium. Subcutaneous injection of these cells generated xenograft tumors in nude mice. Pluripotency markers (SOX-2, OCT4, and Cripto-1) in them were upregulated compared with normal gastric cells. The majority of them expressed CSC markers of CD44, CD54, and EpCAM, and stemness marker of oct-4. STR profiling showed a unique DNA fingerprint. Karyotype also demonstrated multiple aneuploidies and chromosomal translocations. We suggested that the highly tumorigenic BAG50 cell line with stem cell-like phenotypes may provide a valuable in vitro tool to support new diagnostic, prognostic, and predictive biomarkers as well as the development of more effective treatment strategies.
- 29 September 2022
- Published by Springer Nature in Medical Oncology
- Vol. 39  (12) , 1-9
Establishment and characterization of chemotherapy-enriched sphere-forming cells with stemness phenotypes as a new cell line (BAG50) of gastric carcinoma
Gastric cancer is a malignancy with a high mortality rate worldwide. Cancer stem cells (CSCs) are a small subpopulation of tumor cells that possess the tumor-initiating ability, self-renewal capacity, and high resistance to conventional therapies. Due to the diversity and complexity of human tumors, new cell lines are urgently needed to supply clinically and physiologically relevant cancer models. Here, we report establishing a novel cell line (BAG50) with stemness properties. Chemotherapy-enriched sphere-forming cells with CSC properties isolated from a patient with GC were cultured in a serum-containing medium and passaged for up to 51 passages. The colony-forming ability and tumor-forming capacity of BAG50 cells were evaluated in vitro and in vivo. mRNA upregulation of stemness-related transcriptional factors using real-time PCR as well as expression of CSC markers using flow cytometry was investigated. Finally, STR profiling and chromosome studies were performed. BAG50 cells formed floating spheroid colonies in a serum-free medium. Subcutaneous injection of these cells generated xenograft tumors in nude mice. Pluripotency markers (SOX-2, OCT4, and Cripto-1) in them were upregulated compared with normal gastric cells. The majority of them expressed CSC markers of CD44, CD54, and EpCAM, and stemness marker of oct-4. STR profiling showed a unique DNA fingerprint. Karyotype also demonstrated multiple aneuploidies and chromosomal translocations. We suggested that the highly tumorigenic BAG50 cell line with stem cell-like phenotypes may provide a valuable in vitro tool to support new diagnostic, prognostic, and predictive biomarkers as well as the development of more effective treatment strategies.
- Open Access
- 11 February 2022
- Published by Springer Nature in Research Square
Establishment and Characterization of Chemotherapy-Enriched Sphere-Forming Cells with Stemness Phenotypes as A New Cell Line (BAG50) of Gastric Carcinoma
Gastric cancer is a malignancy with a high mortality rate worldwide. Cancer stem cells (CSCs) are a small subpopulation of tumor cells that possess the tumor-initiating ability, self-renewal capacity, and high resistance to conventional therapies. Due to the diversity and complexity of human tumors, new cell lines are urgently needed to supply clinically and physiologically relevant cancer models. Here, we report establishing a novel cell line (BAG50) with stemness properties. Chemotherapy-enriched sphere-forming cells with CSC properties isolated from a patient with GC were cultured in a serum-containing medium and passaged for up to 51 passages. The colony-forming ability and tumor-forming capacity of BAG50 cells were evaluated in vitro and in vivo. mRNA upregulation of stemness-related transcriptional factors using real-time PCR as well as expression of CSC markers using flow cytometry was investigated. Finally, STR profiling and chromosome studies were performed. BAG50 cells formed floating spheroid colonies in a serum-free medium. Subcutaneous injection of these cells generated xenograft tumors in nude mice. Pluripotency markers (SOX-2, OCT4, and Cripto-1) in them were upregulated compared with normal gastric cells. The majority of them expressed CSC markers of CD44, CD54, and EpCAM, and stemness marker of oct-4. STR profiling showed a unique DNA fingerprint. Karyotype also demonstrated multiple aneuploidies and chromosomal translocations. We suggested that the highly tumorigenic BAG50 cell line with stem cell-like phenotypes may provide a valuable in vitro tool to support new diagnostic, prognostic, and predictive biomarkers as well as the development of more effective treatment strategies.
- 11 February 2022
- Published by Springer Nature in Research Square
Open AccessEstablishment and Characterization of Chemotherapy-Enriched Sphere-Forming Cells with Stemness Phenotypes as A New Cell Line (BAG50) of Gastric Carcinoma
Gastric cancer is a malignancy with a high mortality rate worldwide. Cancer stem cells (CSCs) are a small subpopulation of tumor cells that possess the tumor-initiating ability, self-renewal capacity, and high resistance to conventional therapies. Due to the diversity and complexity of human tumors, new cell lines are urgently needed to supply clinically and physiologically relevant cancer models. Here, we report establishing a novel cell line (BAG50) with stemness properties. Chemotherapy-enriched sphere-forming cells with CSC properties isolated from a patient with GC were cultured in a serum-containing medium and passaged for up to 51 passages. The colony-forming ability and tumor-forming capacity of BAG50 cells were evaluated in vitro and in vivo. mRNA upregulation of stemness-related transcriptional factors using real-time PCR as well as expression of CSC markers using flow cytometry was investigated. Finally, STR profiling and chromosome studies were performed. BAG50 cells formed floating spheroid colonies in a serum-free medium. Subcutaneous injection of these cells generated xenograft tumors in nude mice. Pluripotency markers (SOX-2, OCT4, and Cripto-1) in them were upregulated compared with normal gastric cells. The majority of them expressed CSC markers of CD44, CD54, and EpCAM, and stemness marker of oct-4. STR profiling showed a unique DNA fingerprint. Karyotype also demonstrated multiple aneuploidies and chromosomal translocations. We suggested that the highly tumorigenic BAG50 cell line with stem cell-like phenotypes may provide a valuable in vitro tool to support new diagnostic, prognostic, and predictive biomarkers as well as the development of more effective treatment strategies.